Literature DB >> 15353136

General seroprevalence of hepatitis C and hepatitis B virus infections in population.

Nasir Khokhar1, Muzaffar Lateef Gill, Ghazala Javaid Malik.   

Abstract

OBJECTIVE: To determine the prevalence of hepatitis C virus (HCV) and hepatitis B virus (HBV) infection by detection of anti-HCV and hepatitis B surface antigen (HbsAg) in general population of Pakistan.
DESIGN: Observational. PLACE AND DURATION OF STUDY: Community clinic of Shifa International Hospital, Islamabad, from January 1998 to June 2004.
MATERIALS AND METHODS: Sera of healthy adult individuals who presented for medical evaluation as a pre-employment criteria in the Gulf region were examined for presence of hepatitis B surface antigen and anti-HCV antibody. Alanine aminotransferase levels were also determined.
RESULTS: A total of 47,538 individuals were examined. Out of these, 2528 (5.31%) were positive for anti-HCV and 1221 (2.56%) individuals had positive HBsAg. Hepatitis B surface antigen and anti-HCV both were found in 92 (0.19%) individuals. Mean age of subjects, positive for HCV antibody was 44 years and 40.5 years for HBV. Ninety-four percent individuals were males and 6% were females. Alanine aminotransferase (ALT) was normal in 56 % of subjects with positive HCV and 84% of individuals with HBV.
CONCLUSION: This study which evaluated predominantly a healthy male population, showed a high seroprevalence of anti-HCV and average seroprevalence of hepatitis B virus infection. A large majority of these patients was young and had normal ALT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353136     DOI: 09.2004/JCPSP.534536

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  35 in total

1.  External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis.

Authors:  Adnan Agha; Eram Anwar; Kaukab Bashir; Vincenzo Savarino; Edoardo G Giannini
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

2.  Molecular characterization and clinical epidemiology of HCV in District Dir (Lower), Pakistan.

Authors:  Sami Ullah; Muhammad Akram Khan; Shafiq Ur Rahman; Imran Khan; Fazal Akbar; Anshu Babbar
Journal:  Virusdisease       Date:  2018-05-17

3.  Why Should Viral Markers Be Mandatory in Ocular Surgeries: A Hospital Based Retrospective Study.

Authors:  Anita Ambastha; Rakhi Kusumesh; Gyan Bhasker
Journal:  J Clin Diagn Res       Date:  2016-10-01

Review 4.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 5.  Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors.

Authors:  Yasir Waheed; Talha Shafi; Sher Zaman Safi; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

6.  Hepatitis C virus (HCV) status in newborns born to HCV positive women performing intracytoplasmic sperm injection.

Authors:  F Nesrine; H Saleh
Journal:  Afr Health Sci       Date:  2012-03       Impact factor: 0.927

Review 7.  Hepatitis C treatment: current and future perspectives.

Authors:  Saira Munir; Sana Saleem; Muhammad Idrees; Aaliyah Tariq; Sadia Butt; Bisma Rauff; Abrar Hussain; Sadaf Badar; Mahrukh Naudhani; Zareen Fatima; Muhmmad Ali; Liaqat Ali; Madiha Akram; Mahwish Aftab; Bushra Khubaib; Zunaira Awan
Journal:  Virol J       Date:  2010-11-01       Impact factor: 4.099

8.  Prevalence of active hepatitis c virus infection in district Mansehra Pakistan.

Authors:  Amjad Ali; Habib Ahmad; Ijaz Ali; Sheema Khan; Gulshan Zaidi; Muhammad Idrees
Journal:  Virol J       Date:  2010-11-22       Impact factor: 4.099

Review 9.  Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?

Authors:  Ijaz-S Jamall; Shafaq Yusuf; Maimoona Azhar; Selene Jamall
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

Review 10.  Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors.

Authors:  Syed Asad Ali; Rafe M J Donahue; Huma Qureshi; Sten H Vermund
Journal:  Int J Infect Dis       Date:  2008-10-02       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.